ARTICLE | Clinical News

Onbrez Breezhaler indacaterol regulatory update

November 1, 2010 7:00 AM UTC

Novartis disclosed in its 3Q10 earnings that it submitted new data to FDA in September supporting the 75 and 150 µg doses of indacaterol as requested in a 2009 complete response letter for the product...